Entera Bio Ltd - Warrants (02/07/2023) EBIT

The latest EBIT for ENTXW is $0 as of September 2026. That compares with $-8.2M in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of $2T. Investors often review this figure alongside Entera Bio Ltd - Warrants (02/07/2023)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ENTXW's EBIT moved from $-8.2M to $0 — a 100.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Entera Bio Ltd - Warrants (02/07/2023)'s operating scale or balance-sheet position.

Against Healthcare companies, ENTXW currently prints $0 for EBIT, while the sector average sits near $2T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Entera Bio Ltd - Warrants (02/07/2023)'s growth, margins, and balance sheet.

A EBIT figure of $0 for ENTXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $2T. Explore the charts below for those layers of context.

After noting ENTXW's EBIT ($0), review year-over-year change from $-8.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.